456 related articles for article (PubMed ID: 34609073)
1. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients.
Ubachs J; Ziemons J; Soons Z; Aarnoutse R; van Dijk DPJ; Penders J; van Helvoort A; Smidt ML; Kruitwagen RFPM; Baade-Corpelijn L; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2007-2021. PubMed ID: 34609073
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the gut microbiota and short-chain fatty acids characteristics and associations in a cancer cachexia mouse model.
Liu H; Cheng Y; Qu Y; Wu G
Microb Pathog; 2023 Oct; 183():106332. PubMed ID: 37673351
[TBL] [Abstract][Full Text] [Related]
3. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
Wang Q; Chen C; Zuo S; Cao K; Li H
J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and metabolic aspects of cancer cachexia.
Ziemons J; Smidt ML; Damink SO; Rensen SS
Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101508. PubMed ID: 33648847
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
7. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice.
Pötgens SA; Thibaut MM; Joudiou N; Sboarina M; Neyrinck AM; Cani PD; Claus SP; Delzenne NM; Bindels LB
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):456-475. PubMed ID: 33599103
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
9. The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model.
Jeong SM; Jin EJ; Wei S; Bae JH; Ji Y; Jo Y; Jeong JH; Im SJ; Ryu D
BMB Rep; 2023 Jul; 56(7):404-409. PubMed ID: 37220908
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbial Dysbiosis Differs in Two Distinct Cachectic Tumor-Bearing Models Consuming the Same Diet.
Byerley LO; Lorenzen B; Chang HM; Hartman WG; Keenan MJ; Page R; Luo M; Dowd SE; Taylor CM
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613109
[TBL] [Abstract][Full Text] [Related]
11. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of Microbacterial Diversity Is Associated with Functional Prognosis of Stroke.
Zhang X; Wang X; Zhao H; Cao R; Dang Y; Yu B
Neural Plast; 2023; 2023():6297653. PubMed ID: 37197229
[TBL] [Abstract][Full Text] [Related]
13. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.
Liu H; Xi Q; Tan S; Qu Y; Meng Q; Zhang Y; Cheng Y; Wu G
Int Immunopharmacol; 2023 Nov; 124(Pt B):111001. PubMed ID: 37804658
[TBL] [Abstract][Full Text] [Related]
14. Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients.
Ni Y; Lohinai Z; Heshiki Y; Dome B; Moldvay J; Dulka E; Galffy G; Berta J; Weiss GJ; Sommer MOA; Panagiotou G
ISME J; 2021 Nov; 15(11):3207-3220. PubMed ID: 34002024
[TBL] [Abstract][Full Text] [Related]
15. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study.
Verhaar BJH; Collard D; Prodan A; Levels JHM; Zwinderman AH; Bäckhed F; Vogt L; Peters MJL; Muller M; Nieuwdorp M; van den Born BH
Eur Heart J; 2020 Nov; 41(44):4259-4267. PubMed ID: 32869053
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional comparisons of gut microbiome and short-chain fatty acid levels among children with varied weight classifications.
Gyarmati P; Song Y; Dotimas J; Yoshiba G; Christison A
Pediatr Obes; 2021 Jun; 16(6):e12750. PubMed ID: 33174684
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
18. Altered microbial community structure and metabolism in cow's milk allergic mice treated with oral immunotherapy and fructo-oligosaccharides.
Vonk MM; Engen PA; Naqib A; Green SJ; Keshavarzian A; Blokhuis BRJ; Garssen J; Knippels LMJ; van Esch BCAM
Benef Microbes; 2020 Feb; 11(1):19-32. PubMed ID: 32066258
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia.
Chang Y; Chen Y; Zhou Q; Wang C; Chen L; Di W; Zhang Y
Clin Sci (Lond); 2020 Jan; 134(2):289-302. PubMed ID: 31961431
[TBL] [Abstract][Full Text] [Related]
20. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
